Building pharmacovigilance-ready datasets from resource-limited settings: Study of antiretroviral-associated ADRs in Melanesian patients

Open Access

Issue		BIO Web Conf. Volume 226, 2026 The 5^th International Seminar on Science and Technology (ISSTEC 2025)


Article Number		03005
Number of page(s)		11
Section		Health and Life Sciences
DOI		https://doi.org/10.1051/bioconf/202622603005
Published online		06 March 2026

J.C. Mendes, P.F. Bonolo, M.D. Ceccato, E.A. Gomes, F.A. Acurcio, Adverse reactions associated with first-line regimens in patients initiating antiretroviral therapy. Eur. J. Clin. Pharmacol. 74, 1077–1088 (2018). https://doi.org/10.1007/s00228-018-2472-y [Google Scholar]
S. G. Endalamew, S. K. Assefa, M. S. Getachew, F. G. Arage, D. K. Asgedom, B. Terefe, D. F. Teshome, Incidence of adverse drug reactions among HIV patients on antiretroviral drugs in Ethiopia : A systematic review and meta-analysis. AIDS Res. Treat. 40129733 (2025) https://pubmed.ncbi.nlm.nih.gov/40129733/ [Google Scholar]
G.I. Eluwa, T. Badru, K. A. Agu, K. J. Akpoigbe, O. Chabikuli, C. Hamelmann, Adverse drug reactions to antiretroviral therapy: Incidence, type and risk factors in Nigeria. BMC Clin. Pharmacol. 12, 14 (2012). https://doi.org/10.1186/1472-6904-12-14 [Google Scholar]
I.T. Utami, F.R.S. Prakoeswa, N. Lestari, B. Ichsan, Relationship between knowledge level and community stigma toward HIV/AIDS in Indonesia: A literature review. J. Kedokt. Syiah Kuala 23, 99–107 (2023). https://jurnal.usk.ac.id/JKS/article/view/24678 [Google Scholar]
C. Nugroho, T.A.I. Kusumaningrum, Behavioral beliefs and attitudes toward VCT among MSM in Sukoharjo. J. Kesehat. 12, 102–106 (2019). https://journals.ums.ac.id/index.php/JK/article/view/9766 [Google Scholar]
A.Y. Nugraheni, R. Amelia, I.F. Rizki, Evaluasi Terapi Antiretroviral Pasien HIV/AIDS. J. Farmasetis 8, 45–54 (2019). https://doi.org/10.32583/farmasetis.v8i2.567 [Google Scholar]
A. Khan, M. Alanazi, H. Ben Khaled, S. Alanazi, F. H. Malik, Z. U. Rehman, A. Ali, M. I. Siddique, Pharmacovigilance in the era of digital health: Leveraging big data and artificial intelligence for enhanced drug safety monitoring. Asian J. Pharm. 19, 141–152 (2025). https://doi.org/10.22377/ajp.v19i01.6077 [Google Scholar]
M. A. Shamim, M. A. Shamim, P. Arora, P. Dwivedi, Artificial intelligence and big data for pharmacovigilance and patient safety. J. Med. Surg. Public Health, 3, 100139 (2024). https://doi.org/10.1016/j.glmedi.2024.100139 [Google Scholar]
K. Kreimeyer, M. Foster, A. Pandey, N. Arya, G. Halford, S.F. Jones, R. Forshee, M. Walderhaug, T. Botsis, Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review. J. Biomed. Inform. 73, 14–29 (2017). https://doi.org/10.1016/j.jbi.2017.07.012 [Google Scholar]
A. Nagar, J. Gobburu, A. Chakravarty, Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration. Ther. Adv. Drug Saf. 16, 20420986251361435 (2025). https://doi.org/10.1177/20420986251361435 [Google Scholar]
S. Lemeshow, D.W. Hosmer Jr, J. Klar, S.K. Lwanga, Adequacy of sample size in health studies. John Wiley & Sons, Chichester (1990). https://tbrieder.org/publications/books_english/lemeshow_samplesize.pdf [Google Scholar]
C.A. Naranjo, U. Busto, E.M. Sellers, P. Sandor, I. Ruiz, E.A. Roberts, E. Janecek, C. Domecq, D.J. Greenblatt, A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30, 239–245 (1981). https://doi.org/10.1038/clpt.1981.154 [Google Scholar]
R. Srinivasan, G. Ramya, Adverse drug reaction—causality assessment. Int. J. Res. Pharm. Sci. 1, 606–612 (2011). https://ijrps.com/home/article/view/1220 [Google Scholar]
World Health Organization, WHO pharmacovigilance indicators: A practical manual for the assessment of pharmacovigilance systems. WHO Press, Geneva (2020). https://www.who.int/publications/i/item/WHO-MVP-EMP-2015.03 [Google Scholar]
I.R. Edwards, J.K. Aronson, Adverse drug reactions: Definitions, diagnosis, and management. Lancet 356, 1255–1259 (2000). https://doi.org/10.1016/S0140-6736(00)02799-9 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.